The global Respiratory Diagnostics Market was valued at USD 5.14 billion in 2016 and is projected to reach USD 9.35 billion by 2025, growing at a CAGR of 6.87% from 2017 to 2025.
Respiratory Diagnostics is one of the most used technologies in medicinal sector and diagnosis centers. The reason of the market growth is mainly the lifestyle changes in young population and age related symptoms and diseases in geriatric population.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Lung related diseases and infections
1.2 Changes in lifestyle and inclusion of smoking and tobacco consumption
1.3 Rise in geriatric population
1.4 Technological developments
2. Market Restraints
2.1 Risks associated with reimbursements
2.2 Rising Healthcare cost
Market Segmentation:
1. Global Respiratory Diagnostics Market, by Test Type:
1.1 Mechanical Tests
1.1.1 Pulmonary Function Tests
1.1.1.1 Spirometry
1.1.1.2 Peak Flow Test
1.2 OSA Diagnostic Tests
1.3 Other Test Types
1.4 Imaging Tests
1.4.1 X-Ray
1.4.2 Computed Tomography
1.4.3 Magnetic Resonance Imaging (MRI)
1.4.4 Positron Emission Tomography (PET)
1.4.5 Other Imaging Tests
1.5 Traditional Diagnostic Tests
1.5.1 Immunodiagnostics
1.5.2 Biochemical Characterization
1.5.3 Microscopy
1.6 Molecular Diagnostic Tests
1.7 Pcr
1.7.1 Nucleic Acid Amplification Test
1.7.2 In Situ Hybridization
1.7.3 DNA Sequencing & Next-Generation Sequencing (NGS)
1.7.4 Microarrays
1.7.5 Other Molecular Diagnostic Tests
2. Global Respiratory Diagnostics Market, by Products and Services:
2.1 Instruments & Devices
2.2 Assays & Reagents
2.3 Services & Software
3. Global Respiratory Diagnostics Market, by End User:
3.1 Hospital/Clinical Laboratories
3.2 Reference Laboratories
3.3 Physician Offices
3.4 Other End Users
4. Global Respiratory Diagnostics Market, by Disease:
4.1 Tuberculosis
4.2 Asthma
4.3 Lung Cancer
4.4 Chronic Obstructive Pulmonary Disease
4.5 Other Respiratory Diseases
5. Global Respiratory Diagnostics Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Philips Healthcare
2. Becton, Dickinson & Company
3. Abbott Laboratories
4. Thermo Fisher Scientific Inc.
5. Biomérieux
6. Alere Inc.
7. Bio-Rad Laboratories, Inc.
8. Cosmed
9. Seegene Inc.
10. Sdi Diagnostic
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Respiratory Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL RESPIRATORY DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL RESPIRATORY DIAGNOSTICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE
5.1 Mechanical Tests
5.1.1 Pulmonary Function Tests
5.1.1.1 Spirometry
5.1.1.2 Peak Flow Test
5.2 OSA Diagnostic Tests
5.3 Other Test Types
5.4 Imaging Tests
5.4.1 X-Ray
5.4.2 Computed Tomography
5.4.3 Magnetic Resonance Imaging (MRI)
5.4.4 Positron Emission Tomography (PET)
5.4.5 Other Imaging Tests
5.5 Traditional Diagnostic Tests
5.5.1 Immunodiagnostics
5.5.2 Biochemical Characterization
5.5.3 Microscopy
5.6 Molecular Diagnostic Tests
5.7 Pcr
5.7.1 Nucleic Acid Amplification Test
5.7.2 In Situ Hybridization
5.7.3 DNA Sequencing & Next-Generation Sequencing (NGS)
5.7.4 Microarrays
5.7.5 Other Molecular Diagnostic Tests
6 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES
6.1 Instruments & Devices
6.2 Assays & Reagents
6.3 Services & Software
7 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY END USER
7.1 Hospital/Clinical Laboratories
7.2 Reference Laboratories
7.3 Physician Offices
7.4 Other End Users
8 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE
8.1 Tuberculosis
8.2 Asthma
8.3 Lung Cancer
8.4 Chronic Obstructive Pulmonary Disease
8.5 Other Respiratory Diseases
9 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL RESPIRATORY DIAGNOSTICS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Philips Healthcare
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Becton, Dickinson & Company
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Abbott Laboratories
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Biomerieux
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Alere Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Cosmed
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Seegene Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Sdi Diagnostic
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
Market Overview
The Asia Pacific Oxygen Therapy Equipment Market is anticipated to experience significant growth from 2024 to 2034, driven by rising incidences of respiratory diseases, increasing geriatric population, and advancements in healthcare technology. The market is projected to...
Market Overview
The Europe Oxygen Therapy Equipment Market is anticipated to experience significant growth over the next decade, driven by advancements in medical technology, increasing prevalence of respiratory diseases, and a growing aging population. The market is expected to reach a...
Market Overview
The North America Oxygen Therapy Equipment Market is anticipated to experience significant growth from 2024 to 2034. This growth will be driven by a rise in respiratory diseases, technological advancements in oxygen therapy equipment, and an increasing emphasis on home h...
Market Overview
The Global Oxygen Therapy Equipment Market is anticipated to experience robust growth over the next decade, propelled by the rising prevalence of respiratory diseases, increasing geriatric population, and advancements in medical technology. In 2024, the market is valued ...
Market Overview
The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...
Market Overview
The Europe Ambulance Equipment Market is projected to experience substantial growth over the next decade, driven by advancements in medical technology, increasing healthcare expenditure, and the rising incidence of chronic diseases and medical emergencies. The market is ...